Catherine Ellis

9.4k citations

99 papers · 5.1k indexed · 2 hit papers · h-index 28

Impact in

Endocrine and Autonomic Systems top 1%
- Regulation of Appetite and Obesity
Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology

Papers in

Genetics 25
- Myeloproliferative Neoplasms: Diagnosis and Treatment 17
Oncology 41
- HER2/EGFR in Cancer Research 27
- Cancer Immunotherapy and Biomarkers 11
- Cancer Treatment and Pharmacology 10
- Peptidase Inhibition and Analysis 9

Co-authors: José Baselga Harold J. Burstein Kimberly Blackwell George W. Sledge Svetislava J. Vukelja Joyce O’Shaughnessy Joachim Bischoff Hope S. Rugo
Journals: Journal of Clinical Oncology (16 papers)Cancer Research (9 papers)Blood (6 papers)Annals of Oncology (4 papers)HemaSphere (4 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Catherine Ellis

95 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab 2015 · 432 citations

Peers

Countries citing papers authored by Catherine Ellis

Since Specialization

Citations

This map shows the geographic impact of Catherine Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Ellis more than expected).

Fields of papers citing papers by Catherine Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Ellis. The network helps show where Catherine Ellis may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine Ellis Line = papers co-authored together Catherine Ellis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of hemoglobin improvement with momelotinib on survival in patients with myelofibrosis and anemia: Post hoc analyses of the simplify-1 and momentum trials Blood ·Francesca Palandri, Casey L. O’Connell, Pankit Vachhani, Donal P. McLornan, Steffen Koschmieder, Juan Carlos Hernández‐Boluda, Catherine Ellis, Мерцалова Ольга Дмитриевна, Shiyuan Zhang, N. G. Shinde, Rafael Ferrazoli, Jon Nevill	2025	0
2	First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors Journal for ImmunoTherapy of Cancer ·Michele Maio, Víctor Moreno, Juan Martín-Liberal, Frans L. Opdam, Aaron R. Hansen, Todd M. Bauer, Christophe Le Tourneau, Antoîne Italiano, Danny Rischin, Catherine Ellis, David C. Turner, Sapna Yadavilli, Annalisa Ziemens, Steven Hirschfeld, Marc Ballas, Iván Díaz-Padilla, Eric Angevin	2025	1
3	Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2 Advances in Therapy ·Claire Harrison, Alessandro M. Vannucchi, Christian Récher, Francesco Passamonti, Aaron T. Gerds, Juan Carlos Hernández‐Boluda, Abdulraheem Yacoub, Shireen Sirhan, Catherine Ellis, Bharat Patel, Bryan Strouse, Uwe Platzbecker	2024	7
4	POSTER: MPN-551 Clinical Outcomes With Momelotinib vs Ruxolitinib in Patients With Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-1 Clinical Lymphoma Myeloma & Leukemia ·Vikas Gupta, Stephen T. Oh, Timothy Devos, Viviane Dubruille, John Catalano, SAKINAT OLUWABUKONLA FOLORUNSO, Pilar Giraldo, Hiroshi Kosugi, Tomasz Sacha, Jiří Mayer, Árpád Illés, Catherine Ellis, Zhaohui Wang, Jun Kawashima, Ruben A. Mesa	2023	1
5	Adolescence as the Context for Understanding Young Mothers’ Engagement with Health Promotion: A Phenomenological Exploration Children ·Catherine Ellis, Peter Sidebotham	2023	1
6	Decision-making for the infant sleep environment among families with children considered to be at risk of sudden unexpected death in infancy: a systematic review and qualitative metasynthesis BMJ Paediatrics Open ·Anna Pease, Joanna Garstang, Catherine Ellis, D. L. Watson, Jenny Ingram, Christie Cabral, Peter S Blair, Peter Fleming	2021	19
7	Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab) Breast Cancer Research and Treatment ·Luciano Gallinari, Jessica Huang, J. W. Chapman, Kim Leitzel, Suhail M. Ali, Lois E. Shepherd, Wendy R. Parulekar, Catherine Ellis, Hilda Meiryandah Agil, Liting Zhu, Shakeel Virk, Dora Nomikos, Samuel Aparício, Karen A. Gelmon, Walter P. Carney, Allan Lipton	2017	11
8	Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay Clinical Cancer Research ·Aleix Prat, Patricia Galván, Begoña Jiménez, Wesley Buckingham, 康夫金森, Carl Schaper, María Vidal, Martina Álvarez, Nicole Janoszka, Catherine Ellis, Paolo Nucíforo, Sean Ferree, Nuria Ribelles, Bárbara Adamo, Santiago Ramón y Cajal, Vicente Peg, Emilio Alba	2015	64
9	Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone Breast Cancer Research ·Binghe Xu, Zhongzhen Guan, Zhenzhou Shen, Dori GIROUX, Zefei Jiang, Junlan Yang, Michelle DeSilvio, Mark W. Russo, Cornelia Pradita Notoprajitno, Catherine Ellis	2014	23
10	Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Clinical Cancer Research ·Richard S. Finn, Michael F. Press, Judy Dering, Lisa O’Rourke, Allison Florance, Catherine Ellis, Anne‐Marie Martin, Stephen Johnston	2013	20
11	Professional educational interventions designed to improve knowledge and uptake of immunisation. PubMed ·Catherine Ellis, Damian Roland, Mitch Blair	2013	3
12	Assisting healthcare professionals in understanding drivers and barriers to improving pre-school immunisation uptake. PubMed ·Damian Roland, Catherine Ellis, Mitch Blair	2013	5
13	The risk to relatives of patients with sporadic amyotrophic lateral sclerosis Brain ·Martha F. Hanby, Kirsten M. Scott, William J. Scotton, Lokesh Wijesekera, Tom B. Mole, Catherine Ellis, P. Nigel Leigh, Christopher E. Shaw, Ammar Al‐Chalabi	2011	35
14	Does increased residential density around train stations encourage more environmentally sustainable travel behaviour Transport Research Forum ·Catherine Ellis, Bruno Parolin	2010	2
15	Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer Journal of Clinical Oncology ·Kimberly Blackwell, Harold J. Burstein, Anna Maria Storniolo, Hope S. Rugo, George W. Sledge, María Koehler, Catherine Ellis, Michelle Casey, Svetislava J. Vukelja, Joachim Bischoff, José Baselga, Joyce O’Shaughnessy Hit paper breakdown →	2010	701
16	Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor Clinical Cancer Research ·Maurizio Scaltriti, Sarat Chandarlapaty, Ludmila Prudkin, Claudia Aura, José Jiménez, 蔡雨沁, Anne P. Cameron, Marta Guzmán, Josep Lluís Parra, Catherine Ellis, Robert Gagnon, María Koehler, Henry Gómez, Charles E. Geyer, David Cameron, Joaquı́n Arribas, Neal Rosen, José Baselga	2010	114
17	Colonic Adenomatous Polyposis Syndromes: Clinical Management Clinics in Colon and Rectal Surgery ·Catherine Ellis	2008	13
18	Survival of patients with ALS following institution of enteral feeding is related to pre‐procedure oximetry: A retrospective review of 98 patients in a single centre Amyotrophic Lateral Sclerosis ·Ashley Shaw, L Kronbeinictus, Alan Rio, Ammar Al‐Chalabi, Maria E. Sellars, Catherine Ellis, Christopher E. Shaw, Siva Naga Jyothi, Paul S. Sidhu	2006	55
19	Functional characterisation of the human cloned 5‐HT₇ receptor (long form); antagonist profile of SB‐258719 British Journal of Pharmacology ·David R. Thomas, Patrina de Souza Girelli, A. Donald, Derek N. Middlemiss, Graham J. Riley, Jim J. Hagan, Israel Gloger, Catherine Ellis, Ian T. Forbes, Anthony M. Brown	1998	103
20	Cloning and characterization of a human angiotensin II type 1 receptor Biochemical and Biophysical Research Communications ·Derk J. Bergsma, Catherine Ellis, C S Kumar, Parvathi Nuthulaganti, M. Krętowski, Nabil A. Elshourbagy, Christian Chonardo, Jeffrey M. Stadel, Nambi Aiyar	1992	123

About Catherine Ellis

Catherine Ellis is a scholar working on Genetics, Oncology, Endocrine and Autonomic Systems, Hematology and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 5.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Chronic Myeloid Leukemia Treatments (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer Treatment and Pharmacology (10 papers), Peptidase Inhibition and Analysis (9 papers) and Advanced Breast Cancer Therapies (7 papers). The work is most often cited by research in Endocrine and Autonomic Systems (531 citations), Oncology (2.1k citations), Genetics (575 citations), Cancer Research (518 citations) and Radiology, Nuclear Medicine and Imaging (786 citations). Catherine Ellis has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include José Baselga, Harold J. Burstein, Kimberly Blackwell, George W. Sledge, Svetislava J. Vukelja, Joyce O’Shaughnessy, Joachim Bischoff, Hope S. Rugo, Anna Maria Storniolo and Derk J. Bergsma. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Blood, Annals of Oncology and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact